Results 21 to 30 of about 87,683 (298)

PREPARATION OF ANTIBACTERIAL BENTONITE β LACTAM ANTIBIOTIC COMPOSITE

open access: yesEQA, 2018
The adsorption of Doripenem (beta-lactam antibiotic belonging to the subgroup carbapenem) from aqueous solution using bentonite as the adsorbent was studied at various pH of the solution. The doripenem loaded in bentonite which called doripenem-bentonite
Gladdy Waworuntu   +4 more
doaj   +1 more source

Efficacy of Non-Beta-lactam Antibiotics for Prevention of Cesarean Delivery Surgical Site Infections

open access: yesAmerican Journal of Perinatology Reports, 2019
Objective To examine the association between perioperative Beta (β))-lactam versus non-β-lactam antibiotics and cesarean delivery surgical site infection (SSI).
Benjamin S. Harris   +8 more
doaj   +1 more source

Impact of a structured interview on beta-lactam reaction documentation quality

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology, 2021
Incomplete documentation of β-lactam reactions often leads to inappropriate antibiotic prescribing. The objective of this study was to evaluate the impact of a structured interview on the quality of β-lactam reaction documentation.
Cynthia T. Nguyen   +4 more
doaj   +1 more source

PBP4: A New Perspective on Staphylococcus aureus β-Lactam Resistance. [PDF]

open access: yes, 2018
β-lactam antibiotics are excellent drugs for treatment of staphylococcal infections, due to their superior efficacy and safety compared to other drugs.
Chambers, Henry F   +3 more
core   +3 more sources

Molecular Determinants of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus (MRSA): An Updated Review

open access: yesAntibiotics, 2023
The development of antibiotic resistance in Staphylococcus aureus, particularly in methicillin-resistant S. aureus (MRSA), has become a significant health concern worldwide.
Harshad Lade, Jae-Seok Kim
doaj   +1 more source

Differential DNA accessibility to polymerase enables 30-minute phenotypic β-lactam antibiotic susceptibility testing of carbapenem-resistant Enterobacteriaceae [PDF]

open access: yes, 2020
The rise in carbapenem-resistant Enterobacteriaceae (CRE) infections has created a global health emergency, underlining the critical need to develop faster diagnostics to treat swiftly and correctly.
Garner, Omai B.   +5 more
core   +1 more source

Antibiotic Resistance in Pseudomonas Aeruginosa is Associated with Decreased Fitness

open access: yesCellular Physiology and Biochemistry, 2013
The number of clinical specimens containing β-lactam-resistant Pseudomonas aeruginosa isolates is increasing. However, whether resistance is associated with reduced fitness is still uncertain in clinical Pseudomonas aeruginosa isolates. In this study, we
Zhenzhen Sun   +6 more
doaj   +1 more source

Salicylate decreases production of AmpC type β-lactamases and increases susceptibility to β-lactams in aMorganella morganiiclinical isolate [PDF]

open access: yesFEMS Microbiology Letters, 2004
The effect of salicylate, a marRAB inducer, on the resistance to β-lactams was characterized in an AmpC β-lactamase hyperproducer Morganella morganii clinical isolate (the M1 strain). Results were compared with those of the effect of salicylate in a wild-type M. morganii strain.
María M. Tavío   +6 more
openaire   +1 more source

Imide and isatin derivatives as β-lactam mimics of β-lactam antibiotics [PDF]

open access: yes, 2002
Activated γ-lactams, which are derivatives of succinimide, phthalimide and isatin with suitable elements of molecular recognition, have been synthesised as mimics of the ß-lactam antibiotics and their chemical and biological reactivity ...
Casey, Lorraine A.   +4 more
core   +1 more source

Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through β-lactam-enhancer-mechanism-based cefepime/zidebactam

open access: yesmBio, 2023
Multi-drug resistant (MDR) Pseudomonas aeruginosa harbor a complex array of β-lactamases and non-enzymatic resistance mechanisms. In this study, the activity of a β-lactam/β-lactam-enhancer, cefepime/zidebactam, and novel β-lactam/β-lactamase inhibitor ...
Andrea M. Hujer   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy